Abstract

The present invention concerns the development of new pharmacologically active compounds for the treatment of osteoporosis and in general bone diseases characterized by progressive loss of bone mass, such as rheumatoid arthritis, hyperparathyroidism, and bone cancer metastases.

Research Institution

Università di Pisa

Numero di pubblicazione

WO2016071863A1

TRL

n.a.

Technologies, Systems, Applications

New drugs development